Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration.

Autor: Tyrrell, Chris J.1 chris.tyrrell@phnt.swest.nhs.uk, Iversen, Peter2, Tammela, Teuvo3, Anderson, John4, Björk, Thomas5, Kaisary, Amir V.6, Morris, Thomas7
Zdroj: BJU International. Sep2006, Vol. 98 Issue 3, p563-572. 10p. 2 Diagrams, 3 Charts, 3 Graphs.
Databáze: Academic Search Ultimate